NeoGenomics Files 8-K/A Amendment on Officer Compensation
Ticker: NEO · Form: 8-K/A · Filed: Mar 19, 2025 · CIK: 1077183
Sentiment: neutral
Topics: amendment, executive-compensation, board-changes
TL;DR
NeoGenomics amended its 8-K to update exec comp details.
AI Summary
NeoGenomics, Inc. filed an 8-K/A on March 19, 2025, to amend its previous filing regarding the departure of certain officers and the election of directors. The amendment specifically addresses compensatory arrangements for certain officers, providing updated details on their compensation packages.
Why It Matters
This filing provides updated details on executive compensation, which can be important for investors to understand the financial incentives and potential costs associated with the company's leadership.
Risk Assessment
Risk Level: low — This is an amendment to a previous filing, primarily providing updated details on executive compensation and board changes, which typically carries a low immediate risk.
Key Players & Entities
- NEOGENOMICS, INC. (company) — Registrant
- March 18, 2025 (date) — Date of earliest event reported
- March 19, 2025 (date) — Filing Date
- Nevada (jurisdiction) — State of incorporation
- Fort Myers, Florida (location) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K/A filing?
The primary purpose of this 8-K/A filing is to amend a previous report, specifically to provide updated information regarding the departure of certain officers, the election of directors, and compensatory arrangements of certain officers.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 18, 2025.
What is NeoGenomics, Inc.'s state of incorporation?
NeoGenomics, Inc. is incorporated in Nevada.
What is the address of NeoGenomics, Inc.'s principal executive offices?
The address of NeoGenomics, Inc.'s principal executive offices is 9490 NeoGenomics Way, Fort Myers, Florida 33912.
What specific items are being amended or reported on in this 8-K/A?
This 8-K/A filing amends information related to the departure of directors or certain officers, election of directors, and compensatory arrangements of certain officers.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on March 19, 2025 regarding NEOGENOMICS INC (NEO).